The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
618 - Hi there, We have some emails with only company information, no talks about therapeutic area, nothing about brand. We plan to send it through PTM targeting HCPs. Does this need PAAB approval? Thanks
-
There are cases where corporate messages are subject to the PAAB code. See PAAB code section 7.4 for messaging considered to be within the scope of a reviewable corporate message. If you are still uncertain, you could use the opinion service to ensure the piece is exempt (see the fee schedule on our website).
